Notification S.O. 3669(E), dated 4th May, 2015 [N12-GTG]
As at 7 September 2026. In force from 4 May 2015.
S.O. 3669(E).—In exercise of the powers conferred by section 10 of the Clinical Establishments (Registration and Regulation) Act, 2010 (23 of 2010), the Central Government, being satisfied that it is necessary in the public interest so to do, hereby exempts licensees whose the manufacture of drugs does not exceed ten thousand rupees in value in a financial year from the provisions of section 4 of the said Act, subject to the condition that every such person shall intimate the Licensing Authority in writing of the commencement of the manufacture of drugs within fifteen days of such commencement.
Made under
Recital: "In exercise of the powers conferred by section 10 of the Clinical Establishments (Registration and Regulation) Act, 2010 (23 of 2010), the Central Government, being satisfied that it is necessary in the public interest so to do". Names section 10 of the Clinical Establishments (Registration and Regulation) Act, 2010 (23 of 2010) [S25-JPH]. Vires verified.
Acts on (1)
Exempts Section 4, Clinical Establishments (Registration and Regulation) Act, 2010 [S25-JGX], 4 May 2015. "section 4 of the said Act".
Acted on by (0)
none
Not held (0)
none